312 related articles for article (PubMed ID: 16509569)
21. 2-Methylene analogs of 1alpha-hydroxy-19-norvitamin D3: synthesis, biological activities and docking to the ligand binding domain of the rat vitamin D receptor.
Grzywacz P; Plum LA; Sicinska W; Sicinski RR; Prahl JM; DeLuca HF
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):13-7. PubMed ID: 15225739
[TBL] [Abstract][Full Text] [Related]
22. Probing a water channel near the A-ring of receptor-bound 1 alpha,25-dihydroxyvitamin D3 with selected 2 alpha-substituted analogues.
Hourai S; Fujishima T; Kittaka A; Suhara Y; Takayama H; Rochel N; Moras D
J Med Chem; 2006 Aug; 49(17):5199-205. PubMed ID: 16913708
[TBL] [Abstract][Full Text] [Related]
23. 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
Plonska-Ocypa K; Sicinski RR; Plum LA; Grzywacz P; Frelek J; Clagett-Dame M; DeLuca HF
Bioorg Med Chem; 2009 Feb; 17(4):1747-63. PubMed ID: 19167893
[TBL] [Abstract][Full Text] [Related]
24. Identification of a highly potent vitamin D receptor antagonist: (25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro-19,27-dinor-20-epi-vitamin D3 (ADMI3).
Igarashi M; Yoshimoto N; Yamamoto K; Shimizu M; Ishizawa M; Makishima M; DeLuca HF; Yamada S
Arch Biochem Biophys; 2007 Apr; 460(2):240-53. PubMed ID: 17214957
[TBL] [Abstract][Full Text] [Related]
25. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
Sicinski RR; Prahl JM; Smith CM; DeLuca HF
J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D(3) analogues hydroxymethylated at C-26.
Regueira MA; Samanta S; Malloy PJ; Ordonez-Moran P; Resende D; Sussman F; Munoz A; Mourino A; Feldman D; Torneiro M
J Med Chem; 2011 Jun; 54(11):3950-62. PubMed ID: 21524075
[TBL] [Abstract][Full Text] [Related]
27. New derivatives of 1alpha,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity.
Shimizu M; Iwasaki Y; Shimazaki M; Amano Y; Yamamoto K; Reischl W; Yamada S
Bioorg Med Chem Lett; 2005 Mar; 15(5):1451-5. PubMed ID: 15713405
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
Choi M; Makishima M
Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
[TBL] [Abstract][Full Text] [Related]
29. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
[TBL] [Abstract][Full Text] [Related]
30. Structure-function relationships and crystal structures of the vitamin D receptor bound 2 alpha-methyl-(20S,23S)- and 2 alpha-methyl-(20S,23R)-epoxymethano-1 alpha,25-dihydroxyvitamin D3.
Antony P; Sigüeiro R; Huet T; Sato Y; Ramalanjaona N; Rodrigues LC; Mouriño A; Moras D; Rochel N
J Med Chem; 2010 Feb; 53(3):1159-71. PubMed ID: 20070104
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol.
Rochel N; Hourai S; Pérez-García X; Rumbo A; Mourino A; Moras D
Arch Biochem Biophys; 2007 Apr; 460(2):172-6. PubMed ID: 17346665
[TBL] [Abstract][Full Text] [Related]
32. Methyl-introduced A-ring analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological evaluation.
Fujishima T; Tsutsumi R; Negishi Y; Fujii S; Takayama H; Kittaka A; Kurihara M
Anticancer Res; 2006; 26(4A):2633-6. PubMed ID: 16886673
[TBL] [Abstract][Full Text] [Related]
33. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel analogues of 1alpha,25-dihydroxyvitamin D(3) with side chains at C-18.
Momán E; Nicoletti D; Mouriño A
J Org Chem; 2004 Jul; 69(14):4615-25. PubMed ID: 15230583
[TBL] [Abstract][Full Text] [Related]
35. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
[TBL] [Abstract][Full Text] [Related]
36. New analogs of 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 with conformationally restricted side chains: evaluation of biological activity and structural determination of VDR-bound conformations.
Vanhooke JL; Tadi BP; Benning MM; Plum LA; DeLuca HF
Arch Biochem Biophys; 2007 Apr; 460(2):161-5. PubMed ID: 17227670
[TBL] [Abstract][Full Text] [Related]
37. Ligand-mediated conformational changes of the VDR are required for gene transactivation.
Carlberg C
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):227-32. PubMed ID: 15225776
[TBL] [Abstract][Full Text] [Related]
38. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
Vanhooke JL; Benning MM; Bauer CB; Pike JW; DeLuca HF
Biochemistry; 2004 Apr; 43(14):4101-10. PubMed ID: 15065852
[TBL] [Abstract][Full Text] [Related]
39. New derivative of 1alpha,25-dihydroxy-19-norvitamin D3 with 3'-alkoxypropylidene moiety at C-2: synthesis, biological activity and conformational analysis.
Glebocka A; Sicinski RR; DeLuca HF
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):25-30. PubMed ID: 15225741
[TBL] [Abstract][Full Text] [Related]
40. Recent developments of 19-nor-1,25-dihydroxyvitamin D3 analogues.
Zhang CF; Wan RZ; Liu ZP
ChemMedChem; 2013 Aug; 8(8):1249-60. PubMed ID: 23788554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
